Showing results (61-70 of 320) with videos related to

Sort By:
Pageof 32
Anticancer Research|February 1, 2000
Response of PC-3 prostate cancer cells to combination therapy using irradiation with glucocorticoids or doxorubicinA Kruit, C Reyes-Moreno, D W Newling, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
A phase II study of epirubicin in advanced transitional cell bladder cancer. The Yorkshire Urological Cancer Research GroupW G Jones, M P Sokal, M J Ostrowski, et al.
The Prostate|August 10, 1999
Defining an international research agenda for quality of life in men with prostate cancerM S Litwin, J M Fitzpatrick, S D Fossa, et al.
Biochimica Et Biophysica Acta|April 10, 1992
Determination of the position of the Qi.- quinone binding site from the protein surface of the cytochrome bc1 complex in Rhodobacter capsulates chromatophoresS W Meinhardt, T Ohnishi
The Journal of Urology|October 1, 1992
Progression delay of prostate tumor skeletal metastasis effects by bisphosphonatesY C Sun, A A Geldof, D W Newling, et al.
The Journal of Urology|December 20, 2011
Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodesR P Meijer, R P P Meijer, C J M Nunnink, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2013
Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experienceR P Meijer, J A Nieuwenhuijzen, W Meinhardt, et al.
European Urology|July 21, 2001
The use of valrubicin for the chemoresection of superficial bladder cancer -- a marker lesion studyD W Newling, J Hetherington, S K Sundaram, et al.
Cancer|September 1, 1990
EORTC protocol 30853: orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Interim statistical analysis of the side effects of treatmentM R Robinson, L Denis, D W Newling, et al.
BJU International|June 8, 2004
The 24-h frequency-volume chart in adults reporting no voiding complaints: defining reference values and analysing variablesE P van Haarst, E A Heldeweg, D W Newling, et al.
Pageof 32